Cisplatin Disposition and Kidney Injury

NCT03817970 · clinicaltrials.gov ↗

PHASE3

Phase

ACTIVE_NOT_RECRUITING

Status

72

Enrollment

OTHER

Sponsor class

Conditions

Nephrotoxicity

Interventions

DRUG: Granisetron
DRUG: Ondansetron
DRUG: Palonosetron

Sponsor

University of Colorado, Denver

Collaborators

[object Object]
[object Object]
[object Object]